These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23049208)

  • 21. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
    Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.
    Martens K; McMurry HS; Koprowski S; Hum J; Haraga J; Jou JH; Shatzel JJ
    J Clin Gastroenterol; 2022 Jul; 56(6):536-545. PubMed ID: 35537133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
    Gîrleanu I; Trifan A; Stanciu C; Sfarti C
    World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS; Xu Q; Zhao SY; Zhang YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
    [No Abstract]   [Full Text] [Related]  

  • 27. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing perspectives in portal vein thrombosis.
    Janssen HL
    Scand J Gastroenterol Suppl; 2000; (232):69-73. PubMed ID: 11232496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
    Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
    Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
    Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
    J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient portal vein thrombosis in liver cirrhosis.
    Qi X; Guo X; Yoshida EM; Méndez-Sánchez N; De Stefano V; Tacke F; Mancuso A; Sugawara Y; Yang SS; Teschke R; Arora A; Valla DC
    BMC Med; 2018 Jun; 16(1):83. PubMed ID: 29871683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
    La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
    Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
    Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
    Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New targets for the prevention and treatment of cirrhotic portal vein thrombosis].
    Wang YW; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2024 Jun; 32(6):484-488. PubMed ID: 38964888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
    Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.